Healthcare >> CEO Interviews >> November 17, 2022

Interview with the Chairman and CEO: Cytek Biosciences Inc. (NASDAQ:CTKB)

Jiang, Wenbin
Wenbin Jiang, Ph.D., has served as the Chief Executive Officer and a member of the board of directors of Cytek Biosciences Inc. since December 2014. Dr. Jiang is also a co-founder of the company. In 1998, Dr. Jiang co-founded E2O Communications, Inc., a fiber optic subsystems manufacturing company, which was acquired by JDS Uniphase Corporation in 2004. Dr. Jiang is an inventor of more than 95 U.S. patents and an author of five book chapters and over 50 peer-reviewed technical papers. Dr. Jiang holds a B.S. in Physics and M.S. in Optics & Laser Physics from Fudan University and a Ph.D. in Electrical Engineering from the University of California, Santa Barbara. Profile
Word count: 2,996

TWST: Can you describe your company and its history, starting first with what you do?

Dr. Jiang: Flow cytometry technology is a tool used to